Browsing: MBX

Edward T. Mathers, a director and significant shareholder of MBX Biosciences, Inc. (NASDAQ:MBX), recently bolstered his investment in the company…

Recent filings show that an insider at MBX Biosciences, Inc. (NASDAQ:MBX), a pharmaceutical company specializing in novel therapeutics, has made…

An insider at MBX Biosciences, Inc. (NASDAQ:MBX), a pharmaceutical company specializing in therapeutic treatments, recently made a significant purchase of…

NEA 17, a major shareholder in MBX Biosciences, Inc. (NASDAQ:MBX), recently made a significant purchase of the company’s stock. The…

MBX Biosciences, Inc. (NASDAQ:MBX) executives, specializing in pharmaceutical preparations, have recently purchased a significant amount of the company’s common stock.…

In a recent transaction, executives from OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, and OrbiMed Genesis GP LLC collectively…

In a recent market development, Patrick J. Heron, a director and significant shareholder at MBX Biosciences, Inc. (NASDAQ:MBX), demonstrated strong…

MBX Biosciences, Inc.’s director, Aynechi Tiba, recently made a significant investment in the company by acquiring 750,000 shares of common…

In a recent show of confidence in MBX Biosciences, Inc. (NYSE:MBX), Director Carl L. Gordon has made a significant purchase…